Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 16, 2026

Daily Signals

2758 companies scored · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-16 Cut-offs from the 2026-10-16 run
Companies scored 2758 IC ≥ 0 · market cap ≥ $100M
Median forecast -0.41% Alpha · 90D
Long–short spread +5.19% Strong Buy minus Strong Sell, mean
Median IC 0.27 Spearman · 90D
Rating changes ▲ 280 ▼ 460 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · All

296 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
251 IMRXImmuneering Corp Life Sciences 0.26 $232M Unlock rating and forecasts
252 SABSSAB Biotherapeutics, Inc. Life Sciences 0.15 $230M Neutral -0.03% -0.02% ·
253 SIGASIGA TECHNOLOGIES INC Life Sciences 0.47 $228M Unlock rating and forecasts
254 NATRNATURES SUNSHINE PRODUCTS INC Life Sciences 0.56 $222M Unlock rating and forecasts
255 BIOABioAge Labs, Inc. Life Sciences 0.44 $222M Unlock rating and forecasts
256 LXEOLexeo Therapeutics, Inc. Life Sciences 0.06 $217M Unlock rating and forecasts
257 FATEFATE THERAPEUTICS INC Life Sciences 0.12 $214M Unlock rating and forecasts
258 GLSIGreenwich LifeSciences, Inc. Life Sciences 0.11 $214M Unlock rating and forecasts
259 KROSKeros Therapeutics, Inc. Life Sciences 0.15 $211M Neutral +0.03% +0.09% ·
260 PLXProtalix BioTherapeutics, Inc. Life Sciences 0.01 $211M Unlock rating and forecasts
261 ALECAlector, Inc. Life Sciences 0.23 $205M Unlock rating and forecasts
262 ZNTLZentalis Pharmaceuticals, Inc. Life Sciences 0.36 $202M Unlock rating and forecasts
263 NAGENiagen Bioscience, Inc. Life Sciences 0.59 $197M Neutral -0.28% -0.55% ·
264 RNACCartesian Therapeutics, Inc. Life Sciences 0.36 $190M Unlock rating and forecasts
265 AKBAAkebia Therapeutics, Inc. Life Sciences 0.10 $186M Unlock rating and forecasts
266 CGENCOMPUGEN LTD Life Sciences 0.31 $185M Neutral -0.22% -0.41% ·
267 IVVDInvivyd, Inc. Life Sciences 0.05 $182M Unlock rating and forecasts
268 STROSUTRO BIOPHARMA, INC. Life Sciences 0.55 $181M Unlock rating and forecasts
269 PEPGPepGen Inc. Life Sciences 0.26 $180M Unlock rating and forecasts
270 ADCTADC Therapeutics SA Life Sciences 0.29 $179M Unlock rating and forecasts
271 ACOGAlpha Cognition Inc. Life Sciences 0.62 $178M Unlock rating and forecasts
272 ORMPORAMED PHARMACEUTICALS INC. Life Sciences 0.07 $169M Unlock rating and forecasts
273 CMPXCompass Therapeutics, Inc. Life Sciences 0.17 $155M Unlock rating and forecasts
274 CHRSCoherus Oncology, Inc. Life Sciences 0.22 $153M Unlock rating and forecasts
275 MDWDMediWound Ltd. Life Sciences 0.29 $152M Neutral -0.30% -0.59% ·
276 UPBUpstream Bio, Inc. Life Sciences 0.14 $151M Unlock rating and forecasts
277 NBPNovaBridge Biosciences Life Sciences 0.18 $145M Neutral -0.23% -0.43% ·
278 MOLNMOLECULAR PARTNERS AG Life Sciences 0.30 $144M Unlock rating and forecasts
279 MSLESatellos Bioscience Inc. Life Sciences 0.52 $138M Unlock rating and forecasts
280 DERMJourney Medical Corp Life Sciences 0.15 $135M Unlock rating and forecasts
281 IPHAInnate Pharma SA Life Sciences 0.15 $134M Unlock rating and forecasts
282 NKTXNkarta, Inc. Life Sciences 0.03 $129M Unlock rating and forecasts
283 ORGOOrganogenesis Holdings Inc. Life Sciences 0.33 $129M Unlock rating and forecasts
284 ANTXAN2 Therapeutics, Inc. Life Sciences 0.36 $128M Unlock rating and forecasts
285 KRROKorro Bio, Inc. Life Sciences 0.13 $125M Unlock rating and forecasts
286 ARMPArmata Pharmaceuticals, Inc. Life Sciences 0.11 $123M Unlock rating and forecasts
287 ABOSAcumen Pharmaceuticals, Inc. Life Sciences 0.00 $122M Unlock rating and forecasts
288 HUMAHumacyte, Inc. Life Sciences 0.12 $119M Neutral +0.08% +0.19% ▲ 1
289 OTLKOutlook Therapeutics, Inc. Life Sciences 0.48 $119M Unlock rating and forecasts
290 VYGRVoyager Therapeutics, Inc. Life Sciences 0.00 $117M Unlock rating and forecasts
291 NERVMinerva Neurosciences, Inc. Life Sciences 0.14 $112M Unlock rating and forecasts
292 ENGNenGene Therapeutics Inc. Life Sciences 0.32 $112M Unlock rating and forecasts
293 FHTXFoghorn Therapeutics Inc. Life Sciences 0.12 $110M Unlock rating and forecasts
294 HURATuHURA Biosciences, Inc./NV Life Sciences 0.30 $107M Unlock rating and forecasts
295 LENZLENZ Therapeutics, Inc. Life Sciences 0.55 $103M Unlock rating and forecasts
296 INOINOVIO PHARMACEUTICALS, INC. Life Sciences 0.25 $102M Unlock rating and forecasts
251–296 of 296 Previous Next
Since the previous run

Rating changes

▲ 280▼ 460
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.